NCT01718990View on ClinicalTrials.gov

Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2018

Study Completion Date

December 31, 2018

Conditions
Idiopathic Pulmonary Fibrosis (IPF)
Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT01718990 - Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter